50 mg
Trade Name
Cartimov
Hard Capsule
Request Type
New Registration
Drug Type
NCE
Approval Date
SFDA Approved Use
Symptomatic treatment of functional symptoms and signs of osteoarthritis. Note: action onset is deferred: a period of 30 to 45 days precedes analgesic effect onset. Treatment may therefore have to be initiated with standard immediate action onset analgesics/anti- inflammatories.